ReviewBiomolecules2025

Oral and Non-Oral Cholesterol-Lowering Drugs with PCSK9 and Other Biomolecules as Targets: Present Status and Future Prospects.

Ajoy BasakPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.